Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum
- PMID: 38478360
- DOI: 10.1097/ADM.0000000000001283
Real-World Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients With Opioid Use Disorder During the COVID-19 Pandemic: Erratum
Erratum for
-
Real-world Evidence for Impact of Opioid Agonist Therapy on Nonfatal Overdose in Patients with Opioid Use Disorder during the COVID-19 Pandemic.J Addict Med. 2023 Nov-Dec 01;17(6):e374-e381. doi: 10.1097/ADM.0000000000001213. Epub 2023 Aug 11. J Addict Med. 2023. PMID: 37934531
References
REFERENCE
-
- Lee K, Zhao Y, Merali T, et al. Real-world evidence for impact of opioid agonist therapy on nonfatal overdose in patients with opioid use disorder during the COVID-19 pandemic. J Addict Med. 2023;17(6):e374–e381.
Publication types
LinkOut - more resources
Full Text Sources
